Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

Market Cap	9.02B
Revenue (ttm)	2.99B
Net Income (ttm)	191.75M
Shares Out	343.93M
EPS (ttm)	0.55
PE Ratio	47.40
Forward PE	32.78
Dividend	0.05 (0.19%)
Ex-Dividend Date	Jun 6, 2025

Volume	3,611,100
Average Volume	3,365,819
Open	25.71
Previous Close	26.02
Day's Range	25.70 - 26.39
52-Week Range	15.52 - 31.20
Beta	0.51
RSI	56.50
Earnings Date	Oct 30, 2025

About SHE:300702

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It provides fine chemicals and CDMO services. Zhejiang Tianyu Pharmaceutical Co., Ltd. was founded in 1993 and is based in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 4,532
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300702

Financial Performance

In 2024, SHE:300702's revenue was 2.63 billion, an increase of 4.10% compared to the previous year's 2.53 billion. Earnings were 55.94 million, an increase of 104.45%.